Rein Therapeutics RNTX
NASDAQ RNTX
$0.62 +0.03 (+4.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rein Therapeutics (RNTX) Operating Leases (2019 - 2021)

Updated

Rein Therapeutics (RNTX) posted Operating Leases of $69,000 for Q4 2021, down 30.3% from the prior quarter.

Analysis

Rein Therapeutics (RNTX) Operating Leases (2019 - 2021) Analysis & Trends

Since Q1 2019, Rein Therapeutics has reported Operating Leases for 11 quarters.

  • In prior years, Rein Therapeutics' Operating Leases was $4.59 million in FY2019.
  • The Q4 2021 figure stands as the lowest quarterly Operating Leases in data going back to Q1 2019.
  • According to Business Quant data, Operating Leases for the three prior quarters was $99,000 (Q3 2021), $128,000 (Q2 2021) and $124,000 (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Rein Therapeutics 42.04 Mn -1.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 69,000.00
Sep 30, 2021 99,000.00
Jun 30, 2021 128,000.00
Mar 31, 2021 124,000.00
Sep 30, 2020 4.20 Mn
Jun 30, 2020 4.33 Mn
Mar 31, 2020 4.46 Mn
Dec 31, 2019 4.59 Mn
Sep 30, 2019 4.71 Mn
Jun 30, 2019 4.82 Mn
Mar 31, 2019 4.93 Mn
API Access

Rein Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=RNTX&period=max&api_key=YOUR_API_KEY